Back to Authors

Ransohoff, Richard M

0000-0003-0175-6910

Mayo Clinic

Neuroimmunology and Acute Neurology, Biogen, Cambridge, MA 02142, USA. richard.ransohoff@biogen.com jeffrey.bennett@ucdenver.edu.

Citations 1

Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica

Science Translational Medicine | October 12, 2017 | Volume: 9 | Issue: 397 | Pages: No page available

10.1126/scitranslmed.aai9111 | PMID 28679661

An autoantibody target on brain microvascular endothelial cells in patients with neuromyelitis optica may be exploited to manipulate blood-brain barrier permeability.